From January 1, 2023 to March 31, 2023, the company has repurchased 347,200 shares, representing 0.04% for CNY 13.7 million. With this, the company has completed the repurchase of 1,604,500 shares, representing 0.19% for CNY 61 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.96 CNY | -1.06% | +2.68% | -38.21% |
23/05 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
14/05 | Ruibo Pharmaceutical Co., Ltd. announced that it has received CNY 300 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.21% | 1.85B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.